Cardiff Oncology, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardiff Oncology, Inc. (CRDF) on November 10, 2021, covering events occurring on November 9, 2021. The Company is a Delaware corporation headquartered in San Diego, California, and its common stock trades on the Nasdaq Capital Market.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces upcoming corporate events.
Outlook and Management Commentary
Management announced plans to present and participate in virtual one-on-one investor meetings at two upcoming healthcare conferences:
- Jefferies London Healthcare Conference: November 16 – 19, 2021.
- Piper Sandler 33rd Annual Healthcare Conference: November 29 – December 2, 2021.
A press release detailing these events is included as Exhibit 99.1. No specific guidance, risks, or contingencies are detailed in the body of this report.
Key Facts for Investors to Verify
- Confirm the dates and virtual access details for the Jefferies and Piper Sandler conferences.
- Review the full text of the press release (Exhibit 99.1) for any additional commentary not summarized in the 8-K.
- Check subsequent filings for financial results, as this 8-K contains no financial data.